• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » The George Floyd case has rocked a major U.S. medtech hub: Here’s what industry leaders think

The George Floyd case has rocked a major U.S. medtech hub: Here’s what industry leaders think

June 3, 2020 By Nancy Crotti

Memorial to George Floyd in Minneapolis (Image from Boston Scientific)

Major medtech companies with a presence in the Minnesota and elsewhere have been calling for peace, unity and racial justice following the death of George Floyd in police custody and the resulting demonstrations and violence.

Executives from Boston Scientific, Medtronic and the Medical Alley Association have penned open letters expressing their concerns and pledging to do better. Then Edwards Lifesciences and the medical device trade group AdvaMed added statements.

On Monday, Edwards CEO Mike Musallem told employees that Floyd’s death was “tragic and inexcusable.”

“Seeking diverse perspectives is part of our Secret Sauce because it makes us better and stronger, and we need all perspectives now more than ever,” Musallem said in the letter. “As we navigate these difficult times, it’s critical that we continue to treat each of our colleagues, and all people, with the respect, dignity and humanity we all deserve.”

AdvaMed president & CEO Scott Whitaker wrote to members that the trade group is proud of the industry’s employees who are peacefully protesting racial discrimination in the wake of Floyd’s death.

“As a healthcare organization, we recognize that we do not have the solution to a cultural crisis like the one we face today,” Whitaker said in the letter, posted on LinkedIn. “The medical technology community is united in our common mission to improve and save lives. We are united in our support of diversity and equity in our companies. While we continue our single-minded pursuit of medical breakthroughs to treat and cure disease, we must also have a single-minded focus on eradicating the disease of racism in this country and around the world.”

In an op-ed piece in yesterday’s New York Times, writer Thomas Friedman called on business leaders to lead a cultural change in the U.S.

“It is not hopeless,” Friedman said. “I hope America’s principled business leaders, and there are many, can find a way to come together to lead a healing discussion, maybe through the Business Roundtable, in the absence of a president willing and able to do so.”

Thousands of people have taken to the streets across the country since the Memorial Day death of Floyd, 46, in Minneapolis. The unarmed black man died while (now former) Minneapolis police officer Derek Chauvin pressed his knee on Floyd’s neck and bystanders pleaded for the officer to stop.

As a video of Floyd’s death began to circulate, some protestors began staging peaceful demonstrations in the Twin Cities. Others turned to violence, smashing storefront windows, looting, and burning down a police station and several businesses in Minneapolis and St. Paul. Demonstrations continue to spread across the country.

The city of Minneapolis quickly fired Chauvin and three other officers present, two of whom were reportedly seen pressing on Floyd’s back while the third kept bystanders away. Chauvin was initially charged with third-degree murder and manslaughter. Today, Minnesota Attorney General Keith Ellison elevated the one the first charge against Chauvin to second-degree murder and announced that the other three former officers will be charged with aiding and abetting murder, according to a report in the Minneapolis StarTribune.

In an open letter to employees on Friday, Boston Scientific executives noted that the company has about 9,000 workers in the Minneapolis area, and condemned injustice and discrimination.

Medtronic CEO Geoff Martha extended his sympathies to Floyd’s family and to employees who knew Floyd.

“I can’t find the right words to explain this or make it better. It is senseless. Every time I think we are moving beyond these kinds of acts, they happen again,” Martha wrote in an open letter to Medtronic employees, posted on LinkedIn.

“What I can say is that I won’t tolerate it — whether it be the act that killed Mr. Floyd or the acts of those burning this city,” Martha added. “What I can say is that I — and we — must be better than that and that we will continue to give our time, our resources and our attention to make this better.”

Medtronic’s U.S. headquarters are located in Fridley, Minn., about 10 miles from Minneapolis.

Martha said he is contacting “partners” in the city and that he will contribute his own time and resources to improving race relations in the community. The CEO also said he will continue supporting employee diversity and resource groups within the company “to help drive change inside and outside of our walls.”

Minneapolis resident and former Medtronic CEO Bill George said he and his wife were among the protesters who took to a major highway bridge in Minneapolis on Sunday afternoon. In a letter on his website, George called for changing “the deep inequities, racial injustice, and prejudice that people of color have encountered for years” as well as the culture at the Minneapolis Police Department.

Former Minneapolis police officer Derek Chauvin, who was seen on the video kneeling on Floyd’s neck, has been charged with third-degree murder and second-degree manslaughter. Three other officers who were present and involved in Floyd’s arrest have not been charged.

Minneapolis police have a long history of strained relations with the black community. Jamar Clark, 24, was shot in the head in 2015 by police, who were not charged in his death. Weeks of protests followed.

“Changing the culture of the Minneapolis police force is only an essential first step,” George said. “The police must reclaim their sworn obligation to protect and serve. Beyond that, business and community leaders must provide equal opportunities for people of color to progress through their leadership ranks, until the diversity of their leaders reflects the diversity of the people they serve.”

George also called for “moral leaders who call upon ‘the better angels of our nature’ to guide us on this journey,” quoting Abraham Lincoln. “My greatest desire is for people to step up as moral leaders, each in their own way, to restore greatness to our city and our nation by building a just and moral society.”

The Medical Alley Association, a Minnesota-based medtech trade group, also weighed in.

“Just as we have come together to deal with the COVID-19 pandemic, so we can come together to finally make real progress on eliminating the unnecessary divides in our community. These divides keep us from living up to the standards that we adamantly profess as Minnesota values,” said CEO Shaye Mandle in an open letter.

“Inequities are very real in Minnesota. As healthcare professionals, we are in every community and see these inequities and disparities firsthand. We go to work every day, trying to improve the health and save the lives of all Minnesotans and everyone in need around the world. We must work together to resolve these inequities and disparities,” Mandle added. “Let us pledge to not let George Floyd’s death become another tragic footnote, but rather the time that Minnesotans made the commitment to change the way we see our world.”

This article has been updated with statements from Edwards Lifesciences and AdvaMed, as well as information from the Minneapolis StarTribune and the New York Times.

 

 

Filed Under: Business/Financial News, Featured Tagged With: AdvaMed, Boston Scientific, Edwards Lifesciences, Medical Alley, Medtronic

In case you missed it

  • Butterfly Network asks judge to dismiss Fujifilm Sonosite IP suit
  • Stereotaxis stock down amid cloudy outlook
  • BD, Labcorp collaborate on flow cytometry-based diagnostics
  • NeuroOne submits special FDA 510(k) application for Evo sEEG electrode
  • Si-Bone grows sales 15% in Q2
  • FDA approves second IDE study for CereVasc eShunt
  • Nuwellis posts Q2 sales beat
  • Avanos Medical updates full-year revenue guidance on mixed-bag Q2 results
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • Conformis rises on in-line Q2 results
  • ICU Medical stock sinks on Q2 misses, slashed 2022 guidance
  • Vicarious Surgical completes Beta 2 system design
  • Asensus Surgical says procedures up by more than a third in Q2
  • MRI pioneer Dr. Raymond Damadian dies at 86
  • BD makes tender offers for up to $500M of its debt
  • ViewRay moves HQ to Denver
  • Abbott is looking to address biases for cardiovascular patients

RSS From Medical Design & Outsourcing

  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]
  • New method of cardiac ablation used in first in-human trial for ventricular tachycardia
    A new cardiac ablation technique for patients with ventricular tachycardia (VT) has been used in its first in-human multicenter trial involving Mayo Clinic. The new process — needle ablation using in-catheter, heated, saline-enhanced, radio frequency (SERF) energy — creates lesion scars inside the heart muscle where life-threatening arrhythmias cause VT, Mayo Clinic said. Injecting heated saline… […]
  • AdvaMed pushes CMS for proposed TCET pathway rule this year
    The Advanced Medical Technology Association (AdvaMed) is asking the Centers for Medicare & Medicaid Services (CMS) to move fast on a new way to guarantee reimbursement for new medtech innovations. CMS repealed the Medicare Coverage of Innovative Technology (MCIT) program last year but promised to explore other options to improve the coverage process for access… […]

Primary Sidebar

DeviceTalks Weekly

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy